Investigational Drug Information for Nitrendipine
✉ Email this page to a colleague
What is the development status for investigational drug Nitrendipine?
Nitrendipine is an investigational drug.
There have been 9 clinical trials for Nitrendipine.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Hypertension, Systolic Murmurs, and Neoplasm Metastasis. The leading clinical trial sponsors are Merck KGaA, Merck KGaA, Darmstadt, Germany, and Katholieke Universiteit Leuven.
Summary for Nitrendipine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,891 |
| WIPO Patent Applications | 1,995 |
| Japanese Patent Applications | 873 |
| Clinical Trial Progress | Phase 3 (2009-11-01) |
| Vendors | 98 |
Recent Clinical Trials for Nitrendipine
| Title | Sponsor | Phase |
|---|---|---|
| The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability. | Shanghai Jiao Tong University School of Medicine | Phase 4 |
| Coronavirus (COVID-19) ACEi/ARB Investigation | National University of Ireland, Galway, Ireland | Phase 4 |
| Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor | Alphacait, LLC | Phase 2 |
Clinical Trial Summary for Nitrendipine
Top disease conditions for Nitrendipine
Top clinical trial sponsors for Nitrendipine
US Patents for Nitrendipine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
